PPARG and diabetes mellitus: The study of mice with deacetylation-mimetic PPARγ mutations K268R/K293R proved that PPARγ deacetylation can selectively regulate target genes, inhibit lipid oxidation genes with an anti-atherosclerotic effect in the treatment of diabetes, and the improvement of endothelial function [43].